Laviana Pharma

About:

Laviana Pharmatech specializes in providing process and manufacture outsourcing services for the pharmaceutical industry.

Website: http://www.lavianacorp.com/sy

Top Investors: Crystal Pharmatech, LYFE Capital, Yingke Capital, HY Capital, Lotus Lake Ventures

Description:

Laviana Pharma Co., Ltd. founded in 2005 is a high-tech enterprise. It specializes in providing process and manufacture outsourcing services (CDMO) for the pharmaceutical industry. The main scope of services covers all chemistry-related aspects of process development and transformation for the innovative drug substances and products from laboratory scale to commercialized scale, including process research, process development, process optimization, pilot production and large-scale production of intermediates, API starting materials and API (active pharmaceutical ingredient) for pre-clinical, clinical trial materials and commercialized products. It also provides CMC services for IND and NDA submission of innovative developmental drug. It has three wholly-owned subsidiary, namely, Beijing laviana Pharmatech Co., Ltd., Laviana (Tianjin) Pharmatech Development Co., Ltd., and Laviana Corporation incorporated in United States.

Total Funding Amount:

$97.5M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Beijing, Beijing, China

Founded Date:

2005-01-01

Contact Email:

info(AT)lavianacorp.com

Founders:

Guang Yang, Hongqing Chen, Ling Lu, Wenting Chen

Number of Employees:

501-1000

Last Funding Date:

2022-12-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai